Sanara MedTech Inc.
SMTI
$31.05
-$0.85-2.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 24.66% | 21.42% | 26.98% | 41.77% | 66.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.66% | 21.42% | 26.98% | 41.77% | 66.71% |
| Cost of Revenue | -8.95% | -16.53% | -0.84% | 23.45% | 76.63% |
| Gross Profit | 29.89% | 28.09% | 31.64% | 44.72% | 65.26% |
| SG&A Expenses | 26.06% | 21.54% | 22.09% | 24.61% | 33.11% |
| Depreciation & Amortization | 29.90% | 33.99% | 35.78% | 55.00% | 93.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.53% | 14.24% | 17.22% | 25.51% | 41.30% |
| Operating Income | 19.10% | 29.26% | 30.57% | 36.37% | 34.23% |
| Income Before Tax | -1.59% | 36.20% | 58.14% | 68.14% | 37.43% |
| Income Tax Expenses | -- | -- | -- | -- | 100.00% |
| Earnings from Continuing Operations | -1.59% | 23.81% | 18.36% | 45.14% | -11.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.99% | -37.47% | -19.76% | -11.69% | 57.02% |
| Net Income | -2.33% | 23.50% | 18.32% | 45.79% | -10.77% |
| EBIT | 19.10% | 29.26% | 30.57% | 36.37% | 34.23% |
| EBITDA | 52.95% | 59.89% | 55.05% | 58.76% | 54.82% |
| EPS Basic | 1.25% | 26.08% | 19.84% | 47.81% | -3.54% |
| Normalized Basic EPS | -2.68% | 17.05% | 26.80% | 38.06% | 40.18% |
| EPS Diluted | 1.25% | 26.08% | 20.80% | 48.27% | -2.61% |
| Normalized Diluted EPS | -2.68% | 17.05% | 25.73% | 37.28% | 39.49% |
| Average Basic Shares Outstanding | 2.86% | 3.00% | 3.64% | 4.72% | 5.85% |
| Average Diluted Shares Outstanding | 2.86% | 3.00% | 2.46% | 3.51% | 4.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
